Brief: Reviva Pharmaceuticals Reports First Quarter 2023 Results

Reviva Pharmaceuticals Holdings

15/05/2023 22:55

May 15 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
 RVPH.O :
    * REVIVA REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - TOPLINE DATA FOR
PIVOTAL
PHASE 3 RECOVER TRIAL FOR BRILAROXAZINE IN SCHIZOPHRENIA
EXPECTED MID-2023
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - NET LOSS OF ABOUT
$6.6
MILLION, OR $0.30 PER SHARE, FOR THREE MONTHS ENDED MARCH 31,
2023

Source text for Eikon:  ID:nGNX4hVCmh 
Further company coverage:  RVPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))